Sens. Warner, Chambliss Seek Compromise On Budget
Sen. Mark Warner (D-VA) and Sen. Saxby Chambliss (R-GA) are part of a bipartisan group of senators developing ideas for the federal budget. They tell Steve Inskeep the first step to reining in government spending has to be tackling the top four expenditures: Social Security, Medicare, Medicaid and defense spending.
N.J. Gov. Christie Takes On Taboo Topics With Gusto
With straight talk, New Jersey Gov. Chris Christie has taken the GOP by storm since his election in 2009. He came in third in a recent conservative presidential straw poll even though he had not attended the conference. The governor insists he's not interested in the 2012 Republican presidential nomination.
Preparing For Sea Level Rise, Islanders Leave Home
The government of Kiribati, a set of islands in the Pacific Ocean, is worried that climate change and population pressure could make significant parts of the country uninhabitable within the century. With help from abroad, it has begun the slow process of familiarizing residents with nearby Australia.
Sen. Brown Writes He Was Abused As A Child
Republican Sen. Scott Brown of Massachusetts has disclosed that he was sexually abused as a child. The senator spoke to 60 Minutes, ahead of the publication of his new memoir Against All Odds, which comes out next week.
Charitable Deduction Limit: Bad For Art Nonprofits?
In an effort to reduce the deficit, President Obama has proposed a limit on charitable deductions for the top income bracket. Arts nonprofits are concerned that they will be disproportionately affected — at time when they're already hurting from the economic downturn.
Wis. Bill Slashes Collective Bargaining Rights
Lawmakers in Wisconsin are preparing to vote on a bill being called the most aggressive anti-union proposal in the country. Republican Gov. Scott Walker says his bill is aimed at helping state and local governments save money and balance their budgets.
Sanafi Picks Up Genzyme for $20 Billion
French drugmaker Sanofi-Aventis is buying Massachusetts-based Genzyme for more than $20 billion. The acquisition gives Sanofi a foothold in the increasingly important pharmaceutical research community that's grown up around Harvard and MIT.